2013.09.03 Weekly Broadcast Email
following updates were made to the CCCWF CCOP Research Base
for the week of September 3, 2013.
CCCWF CCOP Research Base 13th Annual Meeting will be held October
24-26 in Asheville, NC. Please visit our annual
for the meeting agenda, accommodation information, and registration. Registration
is available until September 23. We
look forward to seeing you in October!
for sites participating in the Statin Study (WFU, SCCC-Forsyth and Charlotte,
Upstate, Greenville, University of Miami and Wichita CCOPs) and any other
Saturday, October 26 at 7 a.m. you are invited to attend an investigator’s
meeting for the “Preventing Anthracycline Cardiotoxicity with Statins” or
PREVENT study. This study will look at the effect of statins on the
cardiovascular health of women receiving anthracycline chemotherapy for Stage
I-III breast cancer, and is set to begin recruiting this fall.
this session, I will be providing an overview of the study design, followed by
a review of the MRI protocol. This session will be essential for
principal investigators, on-site project managers, physicians involved in MRI,
and MRI technicians from the participating CCOP sites. Any CCOP
staff are also welcome to attend and engage in this discussion and question and
look forward to meeting with all of you as we move closer to the opening of
this protocol. See you in October.
Gregory Hundley, M.D.
Investigator, PREVENT study
of Internal Medicine (Cardiology) and Radiology
Forest University School of Medicine
month of August, 25 patients were accrued to CCCWF CCOP Research Base
trials. Congratulations to the Wichita CCOP for accruing the most
patients. See the Research Base website spotlight section for
were 3 adverse events received during the month of August.
AE 13, 99311 AE 3 and 97211 AE 3
have been attached to this email and summarized on the AE page of the website.